A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...

Exclusive: Bruce Miller and Warren Littlefield explain how The Handmaid's Tale's sequel show, The Testaments, approaches ...

With tensions on the rise as the series heads towards the midpoint, here's what the remaining schedule of 'The Handmaid’s Tale' Season 6 looks like.

The Handmaid’s Tale Season 6 finale is just a few weeks away, but fans hoping for a neatly wrapped story to June Osbourne and ...

Hulu's spinoff of 'The Handmaid's Tale' titled 'The Testaments' comes after the original show's sixth and final season ...

As the final season of "The Handmaid's Tale" begins today, we're taking a look back on everything to know about the hit Hulu ...

The most recent trading session ended with Gilead Sciences (GILD) standing at $104.90, reflecting a -0.74% shift from the previouse trading day's closing. This change was narrower than the S&P 500 ...

The resistance against Gilead carries on. Here's what you need to remember before "The Handmaid's Tale" Season 6 starts.

Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...

Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection ...